Hepatocellular carcinoma: signaling pathways and therapeutic advances
Abstract Liver cancer represents a major global health concern, with projections indicating that the number of new cases could surpass 1 million annually by 2025. Hepatocellular carcinoma (HCC) constitutes around 90% of liver cancer cases and is primarily linked to factors incluidng aflatoxin, hepat...
Saved in:
Main Authors: | Jiaojiao Zheng, Siying Wang, Lei Xia, Zhen Sun, Kui Ming Chan, René Bernards, Wenxin Qin, Jinhong Chen, Qiang Xia, Haojie Jin |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2025-02-01
|
Series: | Signal Transduction and Targeted Therapy |
Online Access: | https://doi.org/10.1038/s41392-024-02075-w |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
APT imaging of hepatocellular carcinoma signals an effective therapeutic response in advance of tumor shrinkage
by: Xiaojing Wang, et al.
Published: (2024-12-01) -
The role of inflammasomes in hepatocellular carcinoma: Mechanisms and therapeutic insights
by: Valentina Arrè, et al.
Published: (2025-01-01) -
Inotodiol induces hepatocellular carcinoma apoptosis by activation of MAPK/ERK pathway.
by: Yushuang Xing, et al.
Published: (2025-01-01) -
Depletion and Reversal of Hepatocellular Carcinoma Inducing CTL through ER Stress-Dependent PERK-CHOP Signaling Pathway
by: Mengnan Guo, et al.
Published: (2022-01-01) -
Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations
by: Yingjun Xie, et al.
Published: (2018-01-01)